63 related articles for article (PubMed ID: 24180681)
1. Sporadic subependymal giant cell astrocytoma with somatic
Alassiri AH; Alfayea TM; Aljared TI; Alenezi KR
Neurosciences (Riyadh); 2024 May; 29(2):139-143. PubMed ID: 38740392
[TBL] [Abstract][Full Text] [Related]
2. Bleeding solitary SEGA in non-tuberous sclerosis complex adolescent: a case illustration and review of literature.
Yindeedej V; Rojnueangnit K; Chotsakulthong P; Thamwongskul C
Childs Nerv Syst; 2024 Apr; ():. PubMed ID: 38578478
[TBL] [Abstract][Full Text] [Related]
3. Intraventricular Pilocytic Astrocytoma in Adults: A 25-year Single-Center Case Series and Systematic Review of the Literature.
Woodiwiss T; Vivanco-Suarez J; Matern T; Eschbacher KL; Greenlee JDW
World Neurosurg; 2024 Apr; ():. PubMed ID: 38580091
[TBL] [Abstract][Full Text] [Related]
4. Microneurosurgical removal of thalamic lesions: surgical results and considerations from a large, single-surgeon consecutive series.
Serra C; Türe H; Yaltırık CK; Harput MV; Türe U
J Neurosurg; 2020 Oct; 135(2):458-468. PubMed ID: 33007756
[TBL] [Abstract][Full Text] [Related]
5. Neuroendoscopic resection of intraventricular tumors: a systematic outcomes analysis.
Barber SM; Rangel-Castilla L; Baskin D
Minim Invasive Surg; 2013; 2013():898753. PubMed ID: 24191196
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.
Trelinska J; Dachowska I; Kotulska K; Baranska D; Fendler W; Jozwiak S; Mlynarski W
Pediatr Blood Cancer; 2015 Apr; 62(4):616-21. PubMed ID: 25557360
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report.
Karita H; Tsuda K; Kono M; Yamamoto T; Ihara S
NMC Case Rep J; 2023; 10():291-297. PubMed ID: 37953906
[TBL] [Abstract][Full Text] [Related]
8. MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?
Soleman J; Dvir R; Ben-Sira L; Yalon M; Boop F; Constantini S; Roth J
Childs Nerv Syst; 2021 May; 37(5):1449-1459. PubMed ID: 33821340
[TBL] [Abstract][Full Text] [Related]
9. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
10. Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis.
Frassanito P; Noya C; Tamburrini G
Childs Nerv Syst; 2020 Oct; 36(10):2527-2536. PubMed ID: 32978642
[TBL] [Abstract][Full Text] [Related]
11. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.
Fohlen M; Ferrand-Sorbets S; Delalande O; Dorfmüller G
Childs Nerv Syst; 2018 Aug; 34(8):1511-1519. PubMed ID: 29766265
[TBL] [Abstract][Full Text] [Related]
12. Subependymal Giant Cell Astrocytoma: Associated Hyperproteinorrhachia Causing Shunt Failures and Nonobstructive Hydrocephalus - Report of Successful Treatment with Long-term Follow-up.
Kasper E; Laviv Y; Sebai ME; Lin N; Butler W
Asian J Neurosurg; 2017; 12(4):746-750. PubMed ID: 29114301
[TBL] [Abstract][Full Text] [Related]
13. Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review.
Laviv Y; Kasper BS; Kasper EM
Neurosurg Rev; 2018 Oct; 41(4):957-968. PubMed ID: 28265819
[TBL] [Abstract][Full Text] [Related]
14. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
15. EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Fogarasi A; De Waele L; Bartalini G; Jozwiak S; Laforgia N; Verhelst H; Petrak B; Pedespan JM; Witt O; Castellana R; Crippa S; Gislimberti G; Gyorsok Z
BMC Neurol; 2016 Aug; 16():126. PubMed ID: 27502586
[TBL] [Abstract][Full Text] [Related]
16. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
[TBL] [Abstract][Full Text] [Related]
17. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
[TBL] [Abstract][Full Text] [Related]
18. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
